<SEC-DOCUMENT>0001415889-25-007598-index.html : 20250310
<SEC-HEADER>0001415889-25-007598.hdr.sgml : 20250310
<ACCEPTANCE-DATETIME>20250310200008
ACCESSION NUMBER:		0001415889-25-007598
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250307
FILED AS OF DATE:		20250310
DATE AS OF CHANGE:		20250310

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Bazemore Todd
		CENTRAL INDEX KEY:			0001605767
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38150
		FILM NUMBER:		25725472

	MAIL ADDRESS:	
		STREET 1:		C/O DYAX CORP.
		STREET 2:		55 NETWORK DRIVE
		CITY:			BURLINGTON
		STATE:			MA
		ZIP:			01803

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KALA BIO, Inc.
		CENTRAL INDEX KEY:			0001479419
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				270604595
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1167 MASSACHUSETTS AVENUE
		CITY:			ARLINGTON
		STATE:			MA
		ZIP:			02476
		BUSINESS PHONE:		781-996-5252

	MAIL ADDRESS:	
		STREET 1:		1167 MASSACHUSETTS AVENUE
		CITY:			ARLINGTON
		STATE:			MA
		ZIP:			02476

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Kala Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20091223
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-03102025_080302.xml
<TEXT>
Document 1 - file: form4-03102025_080302.html

Document 1 - RAW XML: form4-03102025_080302.xml

</DOCUMENT>
</SEC-DOCUMENT>